RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
ROSSI D
Collezione ASL Città di Torino
Items : 49
2023 ACR/EULAR classification criteria in existing research cohorts: an international study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2024 Oct 1;63(10):2770-2775. doi: 10.1093/rheumatology/keae058.
2024
ASL Città di Torino
Sciascia S; Roccatello D; Rossi D; Gimen Alonso C; Alba P; Rubini E; Barinotti A; Radin M; Cecchi I; Foddai SG;
Extremely Long-Lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-Based Regimen in Lupus Nephritis. in Kidney international reports / Kidney Int Rep. 2024 Aug 10;9(10):3079-3080. doi: 10.1016/j.ekir.2024.08.008. eCollection 2024 Oct.
2024
ASL Città di Torino
Fenoglio R; Martins E; Mao HA; Rossi D; Schindler T; De Simone E; Sciascia S; Roccatello D;
Fitwalking: A New Frontier for Kidney Patients - A Center's Experience. in Kidney & blood pressure research / Kidney Blood Press Res. 2024;49(1):443-456. doi: 10.1159/000539525. Epub 2024 May 28.
2024
ASL Città di Torino
Roccatello D; Stasi E; Pozzato M; Parodi G; Rossi D;
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology. in Autoimmunity reviews / Autoimmun Rev. 2023 May;22(5):103298. doi: 10.1016/j.autrev.2023.103298. Epub 2023 Feb 14.
2023
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Bentow C; Rossi D; Mahler M; Miraglia P; Arbrile M; Wilson Jones G; Barinotti A; Radin M; Cecchi I;
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Vaccarino A; Fenoglio R; Rossi D; Rubini E; Barinotti A; Cecchi I; Radin M; Sciascia S;
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.
2023
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management. in Drugs / Drugs. 2023 Feb;83(2):117-134. doi: 10.1007/s40265-022-01824-x. Epub 2023 Feb 2.
2023
ASL Città di Torino
Fenoglio R; Rossi D; Sciascia S; Roccatello D;
Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.
2023
ASL Città di Torino
Sciascia S; Cozzi M; Del Vecchio G; De Simone E; Rossi D; Rubini E; Cecchi I; Naretto C; Roccatello D; Fenoglio R; Kamgaing J; Caniggia I;
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions. in Scientific reports / Sci Rep. 2022 Sep 1;12(1):14904. doi: 10.1038/s41598-022-18427-x.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Rossi D; Fenoglio R; Viziello L; Barreca A; Solfietti L; Battaglia L; Naretto C; Sciascia S; Roccatello D;
Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort. in Journal of reproductive immunology / J Reprod Immunol. 2022 Sep;153:103682. doi: 10.1016/j.jri.2022.103682. Epub 2022 Aug 1.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Rossi D; Radin M; Arbrile M;
Renal Fibrosis in Lupus Nephritis. in International journal of molecular sciences / Int J Mol Sci. 2022 Nov 18;23(22):14317. doi: 10.3390/ijms232214317.
2022
ASL Città di Torino
Roccatello D; Rossi D; Wilson Jones G; Mancardi D; Fenoglio R; Cecchi I; Radin M; Barinotti A; Cozzi M; Sciascia S;
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. in Journal of clinical medicine / J Clin Med. 2022 May 25;11(11):2977. doi: 10.3390/jcm11112977.
2022
ASL Città di Torino
Roccatello D; Fenoglio R; Baldovino S; Rossi D; Terzolo E; Menegatti E; Cecchi I; Radin M; Barinotti A; Sciascia S;
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.
2022
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Barinotti A; Foddai SG; Cecchi I; Rubini E; Radin M;
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Rossi D; Menegatti E; Baldovino S; Barinotti A; Favuzzi MD; Crosasso P; Milone V; Osella S; Di Gregorio F; Di Nunzio P; Buccarano N; Arbrile M; Cecchi I; Radin M;
SAFETY and EFFICACY of the INTENSIFIED B CELL DEPLETION INDUCTION THERAPY for PATIENTS with ANCA-ASSOCIATED VASCULITIS and SEVERE RENAL INJURY: A CONTROLLED STUDY in Annals of the Rheumatic Diseases
2022
AOU Città della Salute di Torino
ASL Città di Torino
Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Ferro M; De Simone E; Naretto C; Barreca A; Rossi D; Fenoglio R;
Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab. in Frontiers in medicine / Front Med (Lausanne). 2022 Mar 28;9:819320. doi: 10.3389/fmed.2022.819320. eCollection 2022.
2022
ASL Città di Torino
Roccatello D; Alpa M; Naretto C; Rossi D; Sciascia S; Fenoglio R;
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy. in Frontiers in immunology / Front Immunol. 2022 Mar 24;13:777134. doi: 10.3389/fimmu.2022.777134. eCollection 2022.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Rossi D; De Simone E; Naretto C; Barreca A; Sammartino A; Roccatello D; Sciascia S; Murgia S; Quattrocchio G; Fenoglio R; Ferro M;
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.
2021
AOU Città della Salute di Torino
ASL Città di Torino
AO Ordine Mauriziano
Mengozzi G; Roccatello D; Rossi D; Giachino O; Baldovino S; Vaccarino A; Bazzan M; Rubini E; Bertero MT; Bertolaccini ML; Cecchi I; Sciascia S; Radin M;
A new challenge for lupus nephritis management: Induction therapy without immunosuppressive maintenance regimen. in Autoimmunity reviews / Autoimmun Rev. 2021 Jul;20(7):102844. doi: 10.1016/j.autrev.2021.102844. Epub 2021 May 7.
2021
ASL Città di Torino
Rossi D; Fenoglio R; Sciascia S; Roccatello D;
Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy. in Minerva medica / Minerva Med. 2021 Apr;112(2):162-174. doi: 10.23736/S0026-4806.20.07076-7. Epub 2020 Nov 16.
2021
AOU Città della Salute di Torino
ASL Città di Torino
Barreca A; Roccatello D; Solfietti L; Viziello L; Kalikatzaros I; Ventrella F; Baldovino S; Kamgaing J; Ferro M; Fenoglio R; Sciascia S; Rossi D;
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy. in Kidney international reports / Kidney Int Rep. 2021 Feb 3;6(4):1081-1087. doi: 10.1016/j.ekir.2021.01.027. eCollection 2021 Apr.
2021
ASL Città di Torino
Rossi D; Rahbani E; Rubini E; Quattrocchio G; Ferro M; Fenoglio R; Alpa M; Naretto C; Sciascia S; Roccatello D;
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.
2021
ASL Città di Torino
Roccatello D; Vaccarino A; Rossi D; Barinotti A; Foddai SG; Rubini E; Cecchi I; Radin M; Sciascia S;
Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.
2021
ASL Città di Torino
Roccatello D; Sciascia S; Baldovino S; Menegatti E; Rossi D; Radin M; Arbrile M;
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis. in Autoimmunity reviews / Autoimmun Rev. 2020 Sep;19(9):102622. doi: 10.1016/j.autrev.2020.102622. Epub 2020 Jul 12.
2020
ASL Città di Torino
Sciascia S; Barreca A; Rossi D; Ferro M; Naretto C; Baldovino S; Fenoglio R; Roccatello D;
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino
Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study. in International journal of environmental research and public health / Int J Environ Res Public Health. 2020 May 15;17(10):3469. doi: 10.3390/ijerph17103469.
2020
ASL Città di Torino
Rossi D; Roccatello D; Baldovino S; Foddai SG; Rubini E; Crosasso P; Favuzzi MD; Osella S; Valeria M; Di Gregorio F; Buccarano N; Di Nunzio P; Cecchi I; Radin M; Sciascia S;
CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond. in International journal of molecular sciences / Int J Mol Sci. 2020 Jun 10;21(11):4129. doi: 10.3390/ijms21114129.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Malavasi F; Baldovino S; Barreca A; Ferro M; Rossi D; Naretto C; Sciascia S; Fenoglio R; Roccatello D;
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring. in Autoimmunity reviews / Autoimmun Rev. 2020 Feb;19(2):102449. doi: 10.1016/j.autrev.2019.102449. Epub 2019 Dec 12.
2020
ASL Città di Torino
Roccatello D; Menegatti E; Alba P; Escudero A; Foddai SG; Rubini E; Guiñazu F; Ladehesa PL; Radin M; Rossi D; Massara C; Cecchi I; Sciascia S;
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. in Journal of nephrology / J Nephrol. 2020 Aug;33(4):757-762. doi: 10.1007/s40620-019-00698-9. Epub 2020 Jan 23.
2020
ASL Città di Torino
ASL Torino 5
Roccatello D; Rubini E; Miraglia P; Besso L; Baldovino S; Rossi D; De Marchi A; Fenoglio R; Cecchi I; Sciascia S; Radin M;
Nailfold Capillaroscopy Patterns. in The Israel Medical Association journal : IMAJ
2019
ASL Città di Torino
Rossi D; Sciascia S; Roccatello D;
The cyclophosphamide-sparing role of an intensified b-cells depletion protocol in anca-associated vasculitis in Annals of the Rheumatic Diseases
2019
ASL Città di Torino
Roccatello D; Sciascia S; Fenoglio R; Rossi D;
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. in Annals of the rheumatic diseases / Ann Rheum Dis. 2018 Nov;77(11):1694-1695. doi: 10.1136/annrheumdis-2018-213496. Epub 2018 May 18.
2018
ASL Città di Torino
Roccatello D; Rossi D; Cecchi I; Radin M; Rubini E; Sciascia S;
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort. in Lupus / Lupus. 2018 Jul;27(8):1393-1394. doi: 10.1177/0961203317751645. Epub 2018 Jan 11.
2018
ASL Città di Torino
Menegatti E; Baldovino S; Sandrone M; Radin M; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;
How I treat patients with systemic sclerosis in clinical practice. in Autoimmunity reviews / Autoimmun Rev. 2017 Oct;16(10):1024-1028. doi: 10.1016/j.autrev.2017.07.018. Epub 2017 Aug 1.
2017
ASL Città di Torino
Cozzi F; Roccatello D; Polito P; Sciascia S; Zanatta E; Marson P; Rossi D;
How I treat patients with adult onset Still's disease in clinical practice. in Autoimmunity reviews / Autoimmun Rev. 2017 Oct;16(10):1016-1023. doi: 10.1016/j.autrev.2017.07.017. Epub 2017 Aug 1.
2017
ASL Città di Torino
Modena V; Govoni M; Bortoluzzi A; Rossi D;
Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort. in BMJ open / BMJ Open. 2017 Jun 21;7(6):e015243. doi: 10.1136/bmjopen-2016-015243.
2017
ASL Città di Torino
Baldovino S; Menegatti E; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. in Oncotarget / Oncotarget. 2017 Jun 20;8(25):41764-41777. doi: 10.18632/oncotarget.16986.
2017
ASL Città di Torino
Menegatti E; Fenoglio R; Solfietti L; Rossi D; Sciascia S; Roccatello D; Baldovino S;
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study. in Oncotarget / Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.
2017
ASL Città di Torino
Menegatti E; Baldovino S; Fenoglio R; Radin M; Naretto C; Alpa M; Sciascia S; Rossi D; Roccatello D;
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study in American Journal of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E;
Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study. in American journal of nephrology / Am J Nephrol. 2016;43(4):251-60. doi: 10.1159/000445841. Epub 2016 Apr 29.
2016
ASL Città di Torino
Alpa M; Naretto C; Di Simone D; Menegatti E; Rossi D; Sciascia S; Baldovino S; Roccatello D;
Living with and treating rare diseases: experiences of patients and professional health care providers. in Qualitative health research / Qual Health Res. 2015 May;25(5):636-51. doi: 10.1177/1049732315570116. Epub 2015 Feb 9.
2015
ASL Città di Torino
Simone P; Roccatello D; Rossi D; Finiguerra I; Picco E; Garrino L;
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment. in Autoimmunity reviews / Autoimmun Rev. 2015 Dec;14(12):1123-30. doi: 10.1016/j.autrev.2015.07.017. Epub 2015 Aug 2.
2015
ASL Città di Torino
Simoncini M; Di Simone D; Naretto C; Alpa M; Rossi D; Baldovino S; Sciascia S; Roccatello D; Menegatti E;
Rheumatoid arthritis: Biological therapy other than anti-TNF. in International immunopharmacology
2015
ASL Città di Torino
Rossi D; Modena V; Sciascia S; Roccatello D;
The role of nail-videocapillaroscopy in early diagnosis of scleroderma. in Autoimmunity reviews
2013
ASL Città di Torino
Rossi D; Russo A; Manna E; Binello G; Baldovino S; Sciascia S; Roccatello D;
Thrombin generation assay: Interactions between chronic inflammation and hemostasis in Blood Transfusion
2012
ASL Città di Torino
Stella S; Vaccarino A; Solfietti L; Binello GB; Manna E; Roccatello D; Rossi D; Geninatti S; Montaruli B; Di Simone D; Naretto C; Bazzan M;
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. in Autoimmunity reviews / Autoimmun Rev. 2008 Oct;8(1):56-8. doi: 10.1016/j.autrev.2008.07.027. Epub 2008 Aug 12.
2008
ASL Città di Torino
Baldovino S; Rossi D; Ferrero B; Cavallo R; Naretto C; Menegatti E; Di Simone D; Napoli F; La Grotta R; Sena LM; Roccatello D; Alpa M;
[Antiphospholipid syndrome and kidney]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2007 Mar-Apr;24(2):111-20.
2007
ASL Città di Torino
Rossi D; Giachino O; Bazzan M; Mazzucco G; Roccatello D;
Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren's syndrome, mixedcryoglobulinemia and idiopathic systemic vasculitis in Clinical and Experimental Rheumatology
2007
ASL Città di Torino
Alpa M; Ferrero B; Cavallo R; Perna A; Naretto C; Gennaro M; Di Simone D; Bellizia L; Mansouri M; Rossi D; Modena V; Giachino O; Sena LM; Roccatello D;
Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma in Journal of the National Cancer Institute
2002
ASL Città di Torino
Herman JG; Baylin SB; Carbone A; Vitolo U; Gloghini A; Rossi D; Botto B; Capello D; Zagonel V; Goodman SN; Gaidano G; Esteller M;